Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer
Clinical trial NCT04464174 · COMPLETED
Trial details
- NCT number
- NCT04464174
- Sponsor
- MedSIR
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2023-11-10
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.